Positive News SentimentPositive NewsNYSE:CLB Core Laboratories (CLB) Stock Price, News & Analysis $12.46 +0.68 (+5.73%) Closing price 09/4/2025 03:59 PM EasternExtended Trading$12.48 +0.02 (+0.12%) As of 09/4/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Core Laboratories Stock (NYSE:CLB) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Core Laboratories alerts:Sign Up Key Stats Today's Range$11.80▼$12.6150-Day Range$9.74▼$13.3652-Week Range$9.72▼$21.83Volume532,552 shsAverage Volume427,275 shsMarket Capitalization$584.48 millionP/E Ratio20.10Dividend Yield0.32%Price Target$12.50Consensus RatingHold Company Overview Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets. The company’s portfolio spans two primary service lines: reservoir description and production enhancement. In reservoir description, Core Laboratories performs detailed analyses on drill-cuttings, cores and reservoir fluids to characterize rock and fluid properties. Under production enhancement, the company offers well stimulation, downhole chemistry, and scale and corrosion management solutions designed to improve flow rates and mitigate operational risks. These services are supported by a global network of research laboratories and field service centers equipped with advanced instrumentation. Headquartered in Amsterdam with key operating offices in Houston, Core Laboratories conducts business in more than 50 countries across six continents, serving major international and national oil companies, as well as independents. The company’s engineering and technical teams collaborate closely with clients to tailor solutions to diverse reservoir environments. Under the leadership of President and CEO Clay C. Williams, Core Laboratories continues to invest in innovation and technology development to address evolving challenges in reservoir management and production optimization.AI Generated. May Contain Errors. Read More Core Laboratories Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks38th Percentile Overall ScoreCLB MarketRank™: Core Laboratories scored higher than 38% of companies evaluated by MarketBeat, and ranked 206th out of 267 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingHold Consensus RatingCore Laboratories has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageCore Laboratories has only been the subject of 2 research reports in the past 90 days.Read more about Core Laboratories' stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth15.63% Earnings GrowthEarnings for Core Laboratories are expected to grow by 15.63% in the coming year, from $0.96 to $1.11 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Core Laboratories is 20.10, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 276.59.Price to Earnings Ratio vs. SectorThe P/E ratio of Core Laboratories is 20.10, which means that it is trading at a less expensive P/E ratio than the Energy sector average P/E ratio of about 39.50.Price to Earnings Growth RatioCore Laboratories has a PEG Ratio of 3.56. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCore Laboratories has a P/B Ratio of 2.27. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Core Laboratories' valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted17.12% of the float of Core Laboratories has been sold short.Short Interest Ratio / Days to CoverCore Laboratories has a short interest ratio ("days to cover") of 16.1, which indicates bearish sentiment.Change versus previous monthShort interest in Core Laboratories has recently increased by 5.59%, indicating that investor sentiment is decreasing significantly. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldCore Laboratories has a dividend yield of 0.34%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthCore Laboratories does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Core Laboratories is 6.45%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Core Laboratories will have a dividend payout ratio of 3.60% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.Read more about Core Laboratories' dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted17.12% of the float of Core Laboratories has been sold short.Short Interest Ratio / Days to CoverCore Laboratories has a short interest ratio ("days to cover") of 16.1, which indicates bearish sentiment.Change versus previous monthShort interest in Core Laboratories has recently increased by 5.59%, indicating that investor sentiment is decreasing significantly. News and Social Media3.1 / 5News Sentiment1.61 News SentimentCore Laboratories has a news sentiment score of 1.61. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.82 average news sentiment score of Energy companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Core Laboratories this week, compared to 3 articles on an average week.Search Interest1 people have searched for CLB on MarketBeat in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Core Laboratories insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.94% of the stock of Core Laboratories is held by insiders.Percentage Held by Institutions97.81% of the stock of Core Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Core Laboratories' insider trading history. Receive CLB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CLB Stock News HeadlinesCore Laboratories (CLB) Down 21.7% Since Last Earnings Report: Can It Rebound?August 22, 2025 | finance.yahoo.comCore Labs Posts Flat Revenue in Q2July 28, 2025 | fool.comHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the most famous companies in the world by 2030. | The Oxford Club (Ad)Core Laboratories earnings missed by $0.13, revenue fell short of estimatesJuly 23, 2025 | investing.comCore Laboratories Inc (CLB) Q2 2025 Earnings: EPS at $0.22, Revenue Hits $130. ...July 23, 2025 | gurufocus.comCORE LAB REPORTS SECOND QUARTER 2025 RESULTSJuly 23, 2025 | prnewswire.comCore Laboratories (CLB) Falls Amid a Difficult Time for the Oilfield Services SectorJuly 22, 2025 | finance.yahoo.comCore Laboratories (CLB) Falls Amid a Difficult Time for the Oilfield Services SectorJuly 21, 2025 | insidermonkey.comSee More Headlines CLB Stock Analysis - Frequently Asked Questions How have CLB shares performed this year? Core Laboratories' stock was trading at $17.31 at the beginning of 2025. Since then, CLB stock has decreased by 28.0% and is now trading at $12.4650. How were Core Laboratories' earnings last quarter? Core Laboratories Inc. (NYSE:CLB) released its quarterly earnings data on Wednesday, July, 23rd. The oil and gas company reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.01. Core Laboratories's revenue was down .3% compared to the same quarter last year. Read the conference call transcript. Who are Core Laboratories' major shareholders? Top institutional shareholders of Core Laboratories include Ariel Investments LLC (27.67%), Disciplined Growth Investors Inc. MN (11.60%), Geode Capital Management LLC (2.38%) and Fisher Asset Management LLC (1.85%). View institutional ownership trends. How do I buy shares of Core Laboratories? Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Core Laboratories own? Based on aggregate information from My MarketBeat watchlists, some other companies that Core Laboratories investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AU Optronics (AUOTY) and DiamondRock Hospitality (DRH). Company Calendar Last Earnings7/23/2025Record date for 8/25 Dividend8/04/2025Ex-Dividend for 8/25 Dividend8/04/2025Dividend Payable8/25/2025Today9/04/2025Next Earnings (Estimated)10/22/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorEnergy Industry OIL - FIELD SVCS Sub-IndustryPetroleum And Natural Gas Current SymbolNYSE:CLB CIK1000229 Webwww.corelab.com Phone(713) 328-2673FaxN/AEmployees3,600Year Founded1936Price Target and Rating Average Price Target for Core Laboratories$12.50 High Price Target$13.00 Low Price Target$12.00 Potential Upside/Downside+0.3%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)$0.62 Trailing P/E Ratio20.10 Forward P/E Ratio12.98 P/E Growth3.48Net Income$31.40 million Net Margins5.73% Pretax Margin8.24% Return on Equity14.15% Return on Assets6.18% Debt Debt-to-Equity Ratio0.47 Current Ratio2.27 Quick Ratio1.70 Sales & Book Value Annual Sales$523.85 million Price / Sales1.12 Cash Flow$1.28 per share Price / Cash Flow9.75 Book Value$5.70 per share Price / Book2.19Miscellaneous Outstanding Shares46,890,000Free Float46,453,000Market Cap$584.48 million OptionableOptionable Beta1.46 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (NYSE:CLB) was last updated on 9/5/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Core Laboratories Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Core Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.